Endothelial [tisu]
function [phsf]
Women [popg]
Estrogen [horm, phsu, strd]
Prevention [topp]
Study [mnob]
Objective [inpr]
endothelial dysfunction [dsyn]
atherosclerotic [ftcn]
Process [bpoc]
Often [tmco]
Preceding [tmco]
symptoms [ftcn]
Menopausal [phsf]
hormone treatment [topp]
CARDIOVASCULAR [bdsy]
controversies [socb]
Study [mnob]
Evaluated [ftcn]
effects [qlco]
Menopausal [phsf]
hormone treatment [topp]
Endothelial [tisu]
function [phsf]
Health [idcn]
Recently [tmco]
Menopausal [phsf]
Women [popg]
Methods [inpr]
Endothelial [tisu]
function [phsf]
Pulse volume [fndg]
Digital tonometry [diap]
Reactive Hyperemia [patf]
Index [inpr]
Subset [clas]
Women [popg]
Estrogen [horm, phsu, strd]
Prevention Study [resa]
Reactive Hyperemia [patf]
Index [inpr]
Measured [qlco]
Annually [tmco]
Randomization [resa]
Daily [tmco]
Oral [spco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg% [qnco]
Weekly [tmco]
Transdermal [ftcn]
17 beta-Estradiol [horm, phsu, strd]
TE2 [blor]
mU/g [qnco]
Intermittent [tmco]
Progesterone [horm, phsu, strd]
mg day [qnco]
Daily [tmco]
placebo [topp]
Pills [bodm]
Patch [fndg]
baseline [bodm]
Reactive Hyperemia [patf]
Index [inpr]
Average [qnco]
Mean deviation [clna]
Standard [qlco]
N NOS [aapp, imft]
Over [spco]
Group [idcn]
N NOS [aapp, imft]
TE2 [blor]
N NOS [aapp, imft]
placebo [topp]
N NOS [aapp, imft]
Reactive Hyperemia [patf]
Index [inpr]
Traditional [ftcn]
cardiovascular risk factor [dsyn]
Carotid [bpoc]
Intima [tisu]
Medial [spco]
Thickness [qlco]
Spearman Correlation [inpr]
P NOS [aapp, imft]
0.012" [qnco]
prospective [resa]
Assessment [hlca]
Recently [tmco]
Menopausal [phsf]
Women [popg]
Menopausal [phsf]
hormone treatment [topp]
Altered [ftcn]
Reactive Hyperemia [patf]
Index [inpr]
Compared [acty]
placebo [topp]
